Boston Scientific (BSX) FCF Payout Ratio Growth (1y) (2021 - 2023)
Boston Scientific (BSX) FCF Payout Ratio Growth (1y) (2021 - 2023) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Cover Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.71 Bn | 194.11 Bn | 7.27 Bn | -16.90% |
| 2 | Stryker | 127.04 Bn | 123.56 Bn | 4.50 Bn | -8.00% |
| 3 | Medtronic | 118.81 Bn | 109.59 Bn | 6.41 Bn | 0.45% |
| 4 | Boston Scientific | 73.18 Bn | 72.64 Bn | 3.85 Bn | - |
| 5 | Edwards Lifesciences | 52.03 Bn | 47.78 Bn | 1.35 Bn | - |
| 6 | Dexcom | 34.34 Bn | 32.39 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 33.78 Bn | 31.67 Bn | 2.18 Bn | -88.24% |
| 8 | Koninklijke Philips | 26.35 Bn | 23.03 Bn | 4.55 Bn | -11.29% |
| 9 | Steris | 23.03 Bn | 22.54 Bn | 684.20 Mn | 27.54% |
| 10 | Zimmer Biomet Holdings | 19.18 Bn | 18.77 Bn | 1.54 Bn | -18.40% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | -60.78% |
| Mar 31, 2023 | 326.58% |
| Dec 31, 2022 | -64.37% |
| Sep 30, 2022 | 11.87% |
| Jun 30, 2022 | 165.84% |
| Mar 31, 2022 | -216.76% |
| Dec 31, 2021 | 125.13% |
| Sep 30, 2021 | 65.92% |